The two types of diabetes are referred to as type 1 and type 2. Former names for these conditions were insulin-dependent and non-insulin-dependent diabetes, or juvenile onset and adult onset diabetes.
Robert Ferry Jr., MD, is a U.S. board-certified Pediatric Endocrinologist. After taking his baccalaureate degree from Yale College, receiving his doctoral degree and residency training in pediatrics at University of Texas Health Science Center at San Antonio (UTHSCSA), he completed fellowship training in pediatric endocrinology at The Children’s Hospital of Philadelphia.
DISCLAIMER: The information provided on this channel and its videos is for basic purposes only and must not be thought about as expert advice. We are aiming to offer a best, legitimate, particular, comprehensive information.we are not a licensed expert so make certain with your professional consultant in case you need. All the material released in our channel is our own imagination.
Antihyperglycemic therapy in type 2 diabetes: general recommendations. *If patient does not tolerate or has contraindications to metformin, consider agents from another class in Table 8.1. #GLP-1 receptor agonists and DPP-4 inhibitors should not be prescribed in combination. If a patient with ASCVD is not yet on an agent with evidence of cardiovascular risk reduction, consider adding.
This article needs more medical references for verification or relies too on primary sources. Please review the contents of the article and add the appropriate references if you can. Unsourced or poorly sourced material may be challenged and removed. (February 2018)
There are two major types of diabetes, called type 1 and type 2. Type 1 diabetes was also formerly called insulin dependent diabetes mellitus (IDDM), or juvenile-onset diabetes mellitus. In type 1 diabetes, the pancreas undergoes an autoimmune attack by the body itself, and is rendered incapable of making insulin. Abnormal antibodies have been found in the majority of patients with type 1 diabetes. Antibodies are proteins in the blood that are part of the body’s immune system. The patient with type 1 diabetes must rely on insulin medication for survival.
Incretin mimetics: Incretin mimetics promote insulin secretion by the pancreas. They mimic other natural actions that lower blood sugar level. Exenatide (Byetta) was the first incretin mimetic agent approved in the United States. It is indicated for type 2 diabetes in addition to metformin (Glucophage) or a sulfonylurea when these agents alone cannot control blood sugar level.
Jump up ^ Bartoli E, Fra GP, Carnevale Schianca GP (February 2011). “The oral glucose tolerance test (OGTT) revisited”. European Journal of Internal Medicine. 22 (1): 8–12. doi:10.1016/j.ejim.2010.07.008. PMID 21238885.
. Optimized mealtime insulin dosing for fat and protein in type 1 diabetes: application of a model-based approach to derive insulin doses for open-loop diabetes management. Diabetes Care 2016;39:1631–1634
You may worry that having diabetes means going without foods you enjoy. The good news is that you can still eat your favorite foods, but you might need to eat smaller portions or enjoy them less often. Your health care team will help create a diabetes meal plan for you that meets your needs and likes.
Benefits of control and reduced hospital admission have been reported. However, patients on oral medication who do not self-adjust their drug dosage will miss many of the benefits of self-testing, and so it is questionable in this group. This is particularly so for patients taking monotherapy with metformin who are not at risk of hypoglycaemia. Regular 6 monthly laboratory testing of HbA1c (glycated haemoglobin) provides some assurance of long-term effective control and allows the adjustment of the patient’s routine medication dosages in such cases. High frequency of self-testing in type 2 diabetes has not been shown to be associated with improved control. The argument is made, though, that type 2 patients with poor long term control despite home blood glucose monitoring, either have not had this integrated into their overall management, or are long overdue for tighter control by a switch from oral medication to injected insulin.
Plus, you’ll enjoy unlimited access to Certified Diabetes Educators, dietitians and weight loss counselors, who will help guide you through every step of the journey. So you’ll feel prepared to continue your healthy lifestyle after you reach your goal!
That’s doubly true if you’re middle-aged or older. The fall in estrogen levels associated with menopause can make it difficult for a woman’s body to maintain healthy blood sugar levels, which can increase her risk for diabetes, says Leanne Redman, PhD, an associate professor of endocrinology and women’s health at Louisiana State University’s Pennington Biomedical Research Center (PBRC).
Diabetes mellitus is a metabolic disorder that results from problems controlling the hormone insulin. Diabetes symptoms are a result of higher-than-normal levels of glucose (sugar) in your blood. With type 1 diabetes, symptoms usually develop sooner and at a younger age than with type 2 diabetes. Type 1 diabetes also normally causes more severe symptoms. In fact, because type 2 diabetes signs and symptoms can be minimal in some cases, it sometimes can go diagnosed for a long period of time, causing the problem to worsen and long-term damage to develop.
The first thing to understand when it comes to treating diabetes is your blood glucose level, which is the amount of glucose in the blood. Glucose is a sugar that comes from the foods we eat and also is formed and stored inside the body. It’s the main source of energy for the cells of the body, and is carried to each cell through the blood. Glucose gets into the cells with the help of the hormone insulin.